Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study
Authors:
Open Access
- 9 September 2021
- Vol. 6 (5) , 100258
Abstract
No abstract availableKeywords
Funding Information
- Royal Marsden NHS Foundation Trust
- GlaxoSmithKline
- National Institute for Health Research
- Novartis
- Eli Lilly and Company
- Bayer
- Merck Sharp and Dohme United Kingdom
This publication has 40 references indexed in Scilit:
- Shared Decision Making — The Pinnacle of Patient-Centered CareNew England Journal of Medicine, 2012
- Symptom Burden, Survival and Palliative Care in Advanced Soft Tissue SarcomaSarcoma, 2011
- Experience of Newly Diagnosed Patients With Sarcoma Receiving ChemotherapyOncology Nursing Forum, 2011
- Cancer patient preferences for quality and length of lifeCancer, 2008
- How Would Terminally Ill Patients Have Others Make Decisions for Them in the Event of Decisional Incapacity? A Longitudinal StudyJournal of the American Geriatrics Society, 2007
- The choice is yours? How women with ovarian cancer make sense of treatment choicesPatient Education and Counseling, 2006
- Information giving and decision-making in patients with advanced cancer: A systematic reviewSocial Science & Medicine, 2005
- Striving for quality or length at the end-of-life: attitudes of the Dutch general publicPatient Education and Counseling, 2005
- Treatment decisions in palliative cancer care: Patients' preferences for involvement and doctors' knowledge about itEuropean Journal of Cancer, 1997
- Tradeoffs between Quality and Quantity of LifeMedical Decision Making, 1996